Eyad ALMOUAZEN
Présentation
Sep 2021 – Present: Principal Scientist, Drug Product Development Virbac SA, Carros, France
Lead R&D formulation unit, driving the development of biological drug products through the CMC phase.
Apply QbD principles to enhance formulation performance and ensure robust, scalable manufacturing processes for liquid and lyophilized products.
Spearhead 3 technical transfer projects, overseeing both internal and outsourced manufacturing to ensure seamless execution and compliance with regulatory standards.
Sep 2014 – Sep 2021: Associated Professor University Lyon 1
Teaching at Faculty of Pharmacy ISPB, Pharmaceutical and Cosmetic Technology Department
Research at LAGEP‐ UMR CNRS 5007 – Pharmaceutical Engineering Team
Design and development of innovative dosage forms for therapeutic applications: working on the elaboration of pharmaceutical formulations, the development of required analytical methods and the needed biological evaluations.
2012 – 2014 Temporary Assistant Professor Faculty of Pharmacy ISPB, University Lyon 1, France
Research: oral vaccine development for veterinary application
2009 – 2013 PhD student in Pharmaceutical Technology LAGEP UMR CNRS 5007 and INSERM U1028, University Lyon1, France
Thesis title: Development of polymeric nanoparticles for targeting and modulating macrophage functions. -Retinoic acid and vitamin D3 encapsulation by nanoprecipitation -Evaluation of nanoparticle uptake by macrophages in vitro and in vivo -Assessment of therapeutical potential of developed nanoparticles
Feb – July 2009 MSc Research internship LAGEP UMR CNRS 5007 and INSERM U851, University Lyon1, France
Project title: Use of nano-encapsulated haptens to improve the performance of skin sensitization non-animal test. -Elaboration of hapten loaded polymeric nanoparticle. -Test of nanoparticles on dendritic cells – T-cells co-culture.
Mar – Sep 2008 Formulation Engineer Laboratory of skin care development, L’Oreal-Paris, Chevilly-Larue, France
Project title: New formulation development for cleansing application. -Formulation and stability study of low viscosity emulsions.
Jan – Juin 2007 R&D Engineer Expanscience Laboratories, Damascus, Syria
-Performed new control methods -Validation of quality control protocols.
Compétences
Publications
Publications
Nanoparticles and macrophages enhance anticancer activity of vitamin D3 metabolites9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 2014, Lisbone, Portugal
Communication dans un congrès
hal-02013719
v1
|
|
Development of nanoparticle delivery system for oral vaccination of dogsParavac Meeting, 2014, Cordoba, Spain
Communication dans un congrès
hal-01958034
v1
|
|
Développement de nanoparticules polymères pour le ciblage et la modulation des macrophagesJOURNÉE LYONNAISE AGENTS D’IMAGERIE " Nanoparticules multimodales pour le diagnostic et la thérapie, 2013, Lyon, France
Communication dans un congrès
hal-01958037
v1
|
|
Development of polymeric nanoparticles for targeting and modulating macrophage functions17ème Journée scientifique de l’EDISS, 2012, Lyon, France
Communication dans un congrès
hal-01958047
v1
|
|
Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 2012, Istanbul, Turkey
Communication dans un congrès
hal-01958045
v1
|
|
Development of 25-hydroxyvitamin D3 nanoparticles for application in chemotherapy: formulation study8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 2012, Istanbul, Turkey
Communication dans un congrès
hal-01958046
v1
|
|
Encapsulation of hydrophobic hapten enhances in vitro screening performance of non-soluble skin sensitizingSkin and Formulation 4th Symposium, Jun 2012, Lyon, France
Communication dans un congrès
hal-02044632
v1
|
|
Development of polymeric nanoparticles for targeting and modulating macrophage functions16ème Journée scientifique de l’EDISS, 2011, Lyon, France
Communication dans un congrès
hal-01958057
v1
|
|
Development of polymeric nanoparticles for modulating macrophage functions2nd Conference Innovation in Drug Delivery:From preformulation to development through innovative evaluation process, 2010, Aix en Provence, France
Communication dans un congrès
hal-01958063
v1
|
|
Development of polymeric nanoparticles for modulating macrophage functions: an original strategy of cellular therapy for autoimmune diseases7th world meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 2010, Unknown, Malta
Communication dans un congrès
hal-01958066
v1
|
Nanoparticules pour la liberation d’acides nucleiquesFrance, Patent n° : FR2112931A. 2021
Brevet
hal-04705105
v1
|
|
|
Développement de nanoparticules polymères pour le ciblage des macrophages et la modulation des leurs fonctions physiologiquesMédecine humaine et pathologie. Université Claude Bernard - Lyon I, 2013. Français. ⟨NNT : 2013LYO10121⟩
Thèse
tel-00945306
v1
|